557 Neoadjuvant Camrelizumab in Combination with Albumin Paclitaxel and Cisplatin for Patients with Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)
Regular and Young Investigator Award Abstracts（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined